Guggenheim Capital LLC Haemonetics Corp Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 13,825 shares of HAE stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,825

Previous 13,960 0.97%

Holding current value

$1.23 Million

Previous $1.15 Million 3.73%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.45 - $91.58 $9,780 - $12,363	-135 Reduced 0.97%	13,825 $1.11 Million
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $54,430 - $65,237	-670 Reduced 4.58%	13,960 $1.15 Million
Q1 2024 May 14, 2024	BUY	$71.24 - $85.35 $245,493 - $294,116	3,446 Added 30.81%	14,630 $1.25 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $171,817 - $197,444	2,132 Added 23.55%	11,184 $956,000
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $747,333 - $846,271	9,052 New	9,052 $810,000
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $119,563 - $139,460	-1,619 Reduced 13.4%	10,459 $822,000
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $8,355 - $10,383	-132 Reduced 1.08%	12,078 $894,000
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $32,370 - $43,414	-657 Reduced 5.11%	12,210 $795,000
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $22,979 - $33,190	525 Added 4.25%	12,867 $814,000
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $72,095 - $108,528	-1,455 Reduced 10.55%	12,342 $655,000
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $147,110 - $180,286	2,554 Added 22.72%	13,797 $974,000
Q2 2021 Aug 13, 2021	BUY	$51.81 - $118.56 $98,128 - $224,552	1,894 Added 20.26%	11,243 $749,000
Q1 2021 May 13, 2021	BUY	$111.01 - $139.48 $629,981 - $791,549	5,675 Added 154.46%	9,349 $1.04 Million
Q4 2020 Feb 16, 2021	BUY	$88.75 - $119.95 $326,067 - $440,696	3,674 New	3,674 $436,000
Q2 2020 Aug 14, 2020	SELL	$84.96 - $118.91 $200,420 - $280,508	-2,359 Closed	0 $0
Q1 2020 Jun 02, 2020	SELL	$74.34 - $121.82 $64,824 - $106,227	-872 Reduced 26.99%	2,359 $235,000
Q4 2019 Feb 14, 2020	SELL	$114.37 - $129.46 $280,892 - $317,953	-2,456 Reduced 43.19%	3,231 $371,000
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $143,989 - $170,241	1,229 Added 27.57%	5,687 $717,000
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $34,657 - $51,024	-424 Reduced 8.68%	4,458 $536,000
Q1 2019 May 15, 2019	SELL	$83.25 - $102.12 $56,693 - $69,543	-681 Reduced 12.24%	4,882 $427,000
Q4 2018 Feb 14, 2019	BUY	$90.66 - $116.63 $504,341 - $648,812	5,563 New	5,563 $557,000

Others Institutions Holding HAE

# of Institutions

334

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.58B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Haemonetics Corp Transaction History